NFG
MGNX icon

Next Financial Group’s MacroGenics MGNX Stock Holding History

Next Financial Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$2K – 1877
2017
Q2 		$2K Hold
100
– – ﹤0.01% 1738
2017
Q1 		$2K Hold
100
– – ﹤0.01% 1709
2016
Q4 		$2K Hold
100
– – ﹤0.01% 2172
2016
Q3 		$3K Hold
100
– – ﹤0.01% 2077
2016
Q2 		$2K Hold
100
– – ﹤0.01% 1595
2016
Q1 		$1K Hold
100
– – ﹤0.01% 1643
2015
Q4 		$3K Hold
100
– – ﹤0.01% 1523
2015
Q3 		$2K Hold
100
– – ﹤0.01% 1628
2015
Q2 		$3K Hold
100
– – ﹤0.01% 1603
2015
Q1 		$3K Hold
100
– – ﹤0.01% 1617
2014
Q4 		$4K Hold
100
– – ﹤0.01% 1587
2014
Q3 		$2K Buy
+100
New +$2.07K ﹤0.01% 2317

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Next Financial Group's MGNX Position: Q3 2017 in Review

Next Financial Group sold out of MacroGenics (MGNX) in Q3 2017, closing a stake of 100 shares — an estimated $2K sold.

Next Financial Group first reported a position in MGNX in Q3 2014 and held it in 12 quarters. The position peaked at $4K in Q4 2014. 113 funds tracked by Wall St. Rank hold MGNX as of Q3 2017.

  • Next Financial Group reported no remaining MacroGenics position as of Q3 2017 after selling out during the quarter.
  • Next Financial Group sold 100 MacroGenics shares in Q3 2017, an estimated $2K.
  • Next Financial Group first reported a position in MacroGenics in Q3 2014 and held it in 12 quarters.
  • Next Financial Group's MacroGenics position peaked at $4K in Q4 2014.
  • 113 funds tracked by Wall St. Rank held MacroGenics as of Q3 2017.

Based on Next Financial Group's 13F filing for Q3 2017, filed 8 Nov 2017.